Evidence map›Paper›PMID 40389698›Full record

ArticleInternational wound journal2025

A Scoping Review to Identify Clinical Signs, Symptoms and Biomarkers Reported in the Literature to Be Indicative of Biofilm in Chronic Wounds.

John D Ivory, Laure Perrier, Akke Vellinga, Duygu Sezgin, Chloe M Hobbs, Cathal Ffrench, Patricia M Coutts, James P O'Gara, Georgina Gethin

Abstract readScoping Review
In one paragraph

Article in International wound journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

John D IvorySchool of Nursing & Midwifery, Áras Moyola, University of Galway, Galway, Ireland.ORCID https://orcid.org/0000-0002-8445-4602
Laure PerrierOntario Hospital Association (OHA), Toronto, Ontario, Canada.
Akke VellingaAlliance for Research & Innovation in Wounds (ARIW), School of Nursing & Midwifery, Áras Moyola, University of Galway, Galway, Ireland.
Duygu SezginSchool of Nursing & Midwifery, Áras Moyola, University of Galway, Galway, Ireland.
Chloe M HobbsAlliance for Research & Innovation in Wounds (ARIW), School of Nursing & Midwifery, Áras Moyola, University of Galway, Galway, Ireland.
Cathal FfrenchSchool of Nursing & Midwifery, Áras Moyola, University of Galway, Galway, Ireland.
Patricia M CouttsWounds Canada, North York, Ontario, Canada.
James P O'GaraAlliance for Research & Innovation in Wounds (ARIW), School of Nursing & Midwifery, Áras Moyola, University of Galway, Galway, Ireland.
Georgina GethinSchool of Nursing & Midwifery, Áras Moyola, University of Galway, Galway, Ireland.

Funding

Health Research Board (HRB) Collaborative Doctoral Awards (CDA) Diabetic Foot Disease: from Prevention to Improved patient Outcones (DFD PRIMO) CDA-2019-007Irish Research Council GOIPG/2020/535
6 · The paper itself

Abstract

The objective of this review was to identify clinical signs/symptoms reported in the literature to be indicative of biofilm in chronic wounds. The Preferred Reporting Items for Systematic Reviews and Meta-Analysis extension for Scoping Reviews, and the Joanna Briggs Institute Evidence Synthesis manual guided review conduct. Any article/study type reporting signs/symptoms of biofilm in adults with venous, diabetic, pressure and/or mixed arterial/venous ulcers was eligible. Medline, Embase, CINAHL, Cochrane CENTRAL and the Bielefeld Academic Search Engine were searched. Titles/abstracts and full-text articles were screened against eligibility criteria. One-hundred and eleven reports of 109 articles were included. They provided 830 accounts of clinical signs/ symptoms being indicative of biofilm. These were categorised into 26 statements. Visual indicators such as a shiny, slimy layer on a non-healing wound surface quickly reforming in the absence of frequent cleansing or debridement represented 24% of accounts, followed by failed response to antimicrobial therapies (15%), and failure of wound to close or progress to healing despite optimal management strategies (13%). Wound duration > 6 weeks and extreme tolerance to host defences represented 1% of accounts. Clinical signs/symptoms are recommended and used as indicators of biofilm presence in chronic wounds but with little supporting validation data.

Indexed as

BiofilmsWound HealingWound InfectionAdultAgedBiomarkersChronic DiseaseFemaleHumansMaleMiddle AgedBiomarkersbiofilmschronic woundsscoping reviewsigns and symptomswound healing

Identifiers

PMID40389698
PMCPMC12088863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.